Poland· PL-100526878
Voranigo
A isocitrate dehydrogenase (idh) inhibitors product containing vorasidenibum, registered in Poland by Les Laboratoires Servier.
Checked against URPL (Poland) on
Informational only — not a medical device.
The record
At a glance
URPL (Poland)- Active substance
- Vorasidenibum
- Manufacturer
- Les Laboratoires Servier
- Country
- Poland (PL)
- ATC code
- L01XM
- ATC class
- Isocitrate dehydrogenase (IDH) inhibitors
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin03664898124643
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Vorasidenibum in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesVORANIGOServier Pharmaceuticals LLC
- SpainVORANIGO 40 MG COMPRIMIDOS RECUBIERTOS CON PELICULALes Laboratoires Servier
- FranceVORANIGO 40 mg, comprimé pelliculéLES LABORATOIRES SERVIER
- SwitzerlandVoranigo 40 mg, comprimés pelliculésServier (Suisse) SA
- NorwayVoranigoLes Laboratoires Servier
- SwedenVoranigo 40 mg Filmdragerad tablettLes Laboratoires Servier
- NetherlandsVoranigo 40 mg filmomhulde tablettenLes Laboratoires Servier
- United KingdomVoranigo 10mg tabletsServier Laboratories Ltd
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Voranigo
- Liechtenstein · Voranigo
- Norway · Voranigo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/0a261886-5979-45fa-a4d4-700dfe75a21d GET /v1/drugs/0a261886-5979-45fa-a4d4-700dfe75a21d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "40 mg",
"packaging": "Rpz ¦ EU/1/25/1912/002 ¦ 164150\n30 tabl.\n¦ UR/Z/4b/260/25 - 03664898124643 ¦ UR/Z/4b/213/26 - 03664898124643",
"substance": "Vorasidenibum 40 mg",
"common_name": "Vorasidenibum",
"pl_product_id": "100526878",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about vorasidenibum.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.